Skip to content
stoqly

Rocket Lab Corp

RKLB Nasdaq Guided Missiles & Space Vehicles & Parts Financials FY2020–FY2025

Revenue Total sales reported in the income statement.
$602M
38.0% vs prior year
Operating margin Operating income as a share of revenue.
βˆ’38.0%
5.5 pts
Net income Profit after all expenses, interest and tax.
βˆ’$198M
Free cash flow Cash from operations minus capital spending.
βˆ’$322M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
βˆ’21.1%
27.5 pts
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On βˆ’$0.27 EPS (TTM)

What Rocket Lab Corp does

No business description yet.

Legal name
Rocket Lab Corp
Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Feb 26, 2026
Accession Β· CIK
0001819994-26-000013
0001819994

Revenue and margins

Rocket Lab Corp had $602M of revenue in fiscal 2025, up 38.0% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was βˆ’$322M in fiscal 2025, βˆ’53.5% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Rocket Lab Corp returned β€” to shareholders in fiscal 2025. The diluted share count rose 7.0%.

Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Rocket Lab Corp can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $691M$472M$245M$419M$1.0B
Debt incl. finance leases $100M$119M$15.6M$361M$167M
Debt / equity 0.1x0.2x0.0x0.9x0.1x
Interest coverage β€”β€”βˆ’10.2xβˆ’7.3xβˆ’8.6x
Current ratio 8.0x4.1x2.1x2.0x4.1x
Quick ratio 7.5x3.5x1.7x1.7x3.6x
Total assets $981M$989M$941M$1.2B$2.3B
Total liabilities $282M$316M$387M$802M$603M
Shareholders' equity $698M$673M$555M$382M$1.7B
Net debt (βˆ’ = net cash) βˆ’$591Mβˆ’$353Mβˆ’$229Mβˆ’$58.4Mβˆ’$849M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY20FY21FY22FY23FY24FY25
Net income is positive βœ• βœ• βœ• βœ• βœ• βœ•
Cash from operations is positive βœ• βœ• βœ• βœ• βœ• βœ•
Return on assets rose β€” βœ“ βœ• βœ• βœ“ βœ“
Cash from operations exceeds net income βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Debt fell relative to assets β€” βœ• βœ• βœ“ βœ• βœ“
Current ratio rose β€” βœ“ βœ• βœ• βœ• βœ“
Share count didn't rise β€” βœ• βœ• βœ• βœ• βœ•
Gross margin rose β€” βœ“ βœ“ βœ“ βœ“ βœ“
Revenue rose relative to assets β€” βœ• βœ“ βœ“ βœ“ βœ•
F-score β€” / 34 / 93 / 94 / 94 / 95 / 9
Accruals ratio βˆ’14.5%βˆ’7.8%βˆ’3.0%βˆ’8.7%βˆ’13.3%βˆ’1.9%
Altman Z'' βˆ’5.865.423.18βˆ’0.16βˆ’0.863.83

6 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY20FY21FY22FY23FY24FY25
Income statement
Revenue $35.2M $62.2M $211M $245M $436M $602M
Gross profit βˆ’$11.8M βˆ’$1.9M $19.0M $51.4M $116M $207M
Research and development $19.1M $41.8M $65.2M $119M $174M $271M
Operating income βˆ’$55.0M βˆ’$102M βˆ’$135M βˆ’$178M βˆ’$190M βˆ’$229M
Interest expense β€” β€” β€” $17.5M $26.2M $26.5M
Pretax income βˆ’$54.5M βˆ’$125M βˆ’$133M βˆ’$179M βˆ’$189M βˆ’$226M
Income tax $0.5M βˆ’$7.5M $3.0M $3.7M $0.8M βˆ’$27.7M
Net income βˆ’$55.0M βˆ’$117M βˆ’$136M βˆ’$183M βˆ’$190M βˆ’$198M
Diluted EPS βˆ’$0.73 βˆ’$0.56 βˆ’$0.29 βˆ’$0.38 βˆ’$0.38 βˆ’$0.37
Diluted shares 0.08B 0.21B 0.47B 0.48B 0.50B 0.53B
Cash flow
Cash from operations βˆ’$27.8M βˆ’$71.8M βˆ’$107M βˆ’$98.9M βˆ’$48.9M βˆ’$166M
Capital expenditure $25.1M $25.7M $42.4M $54.7M $67.1M $156M
Free cash flow βˆ’$52.9M βˆ’$97.5M βˆ’$149M βˆ’$154M βˆ’$116M βˆ’$322M
Depreciation and amortization $9.3M $10.9M $29.9M $29.7M $33.7M $43.9M
Stock-based compensation $4.2M $32.6M $55.6M $53.5M $56.8M $71.1M
Acquisitions $12.2M $66.4M $65.8M $19.0M $0.0M $132M
Balance sheet
Cash and short-term investments $52.8M $691M $472M $245M $419M $1.0B
Total debt $0.0M $100M $103M $0.0M $345M $152M
Finance lease liabilities β€” β€” $15.9M $15.6M $15.2M $15.0M
Current assets $93.1M $775M $662M $477M $693M $1.4B
Current liabilities $48.4M $96.3M $163M $223M $340M $334M
Inventory $26.1M $47.9M $92.3M $108M $119M $158M
Property and equipment, net $49.8M $65.3M $102M $145M $195M $319M
Goodwill $3.1M $43.3M $71.0M $71.0M $71.0M $206M
Intangible assets $11.3M $57.5M $79.7M $68.1M $58.6M $225M
Total assets $188M $981M $989M $941M $1.2B $2.3B
Total liabilities $79.6M $282M $316M $387M $802M $603M
Preferred stock $0.0M β€” β€” $0.0M $0.0M $0.0M
Shareholders' equity βˆ’$167M $698M $673M $555M $382M $1.7B
Margins
Gross margin βˆ’33.6% βˆ’3.0% 9.0% 21.0% 26.6% 34.4%
Operating margin βˆ’156.3% βˆ’164.0% βˆ’64.1% βˆ’72.7% βˆ’43.5% βˆ’38.0%
EBITDA margin βˆ’129.7% βˆ’146.5% βˆ’49.9% βˆ’60.6% βˆ’35.8% βˆ’30.7%
Net margin βˆ’156.4% βˆ’188.5% βˆ’64.4% βˆ’74.6% βˆ’43.6% βˆ’32.9%
FCF margin βˆ’150.4% βˆ’156.6% βˆ’70.6% βˆ’62.8% βˆ’26.6% βˆ’53.5%
Returns
Return on capital β€” βˆ’74.9% βˆ’35.1% βˆ’45.4% βˆ’48.5% βˆ’21.1%
Return on capital employed βˆ’39.4% βˆ’11.5% βˆ’16.4% βˆ’24.8% βˆ’22.5% βˆ’11.5%
Return on equity β€” βˆ’44.1% βˆ’19.8% βˆ’29.7% βˆ’40.6% βˆ’18.8%
Return on assets βˆ’29.3% βˆ’20.1% βˆ’13.8% βˆ’18.9% βˆ’17.9% βˆ’11.3%
Return on tangible equity β€” βˆ’19.6% βˆ’26.0% βˆ’43.9% βˆ’75.2% βˆ’15.3%
Growth
Revenue growth β€” 77.0% 239.0% 15.9% 78.3% 38.0%
Share count change β€” 178.3% 122.1% 3.3% 2.9% 7.0%
Financial health
Debt / equity β€” 0.1x 0.2x 0.0x 0.9x 0.1x
Interest coverage β€” β€” β€” βˆ’10.2x βˆ’7.3x βˆ’8.6x
Current ratio 1.9x 8.0x 4.1x 2.1x 2.0x 4.1x
Quick ratio 1.4x 7.5x 3.5x 1.7x 1.7x 3.6x
Capital allocation
Capex / revenue 71.4% 41.3% 20.1% 22.4% 15.4% 26.0%
Stock comp / revenue 12.0% 52.3% 26.4% 21.9% 13.0% 11.8%
Quality scores
Piotroski F-score β€” 4.0 3.0 4.0 4.0 5.0
Altman Z'' βˆ’5.9 5.4 3.2 βˆ’0.2 βˆ’0.9 3.8
Accruals ratio βˆ’14.5% βˆ’7.8% βˆ’3.0% βˆ’8.7% βˆ’13.3% βˆ’1.9%

Source: SEC EDGAR XBRL filings (CIK 0001819994). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open